Cisplatin/Paclitaxel/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cisplatin, paclitaxel, and pembrolizumab that can be used in the treatment of cervical, head and neck, vaginal and metastatic squamous non-small cell lung cancer (NSCLC).

**Synonyms:** - Cisplatin, Paclitaxel, Pembrolizumab - Cisplatin-Paclitaxel-Pembrolizumab - Cisplatin-Paclitaxel-Pembrolizumab Regimen - Cisplatin/Paclitaxel/Pembrolizumab